GangliosideGM2 is a glycosphingolipid component of cellular membranes, primarily the plasma membrane. Levels of gangliosideGM2 are elevated in the brain of patients with Sandhoff disease, as well as feline and mouse models of the disease. GangliosideGM2 accumulates in the lysosomes of individuals with Tay-Sachs disease and GM2-activator deficiency, as well as in the CNS of patients with and animal models of mucopolysaccharide storage disorders and Niemann-Pick disease types A, C1, and C2. GangliosideGM2 mixture contains gangliosideGM2 molecular species with C18:1 and C20:1 sphingoid backbones.
GangliosideGM2 asialo (asialo- GM2) is a glycosphingolipid containing three monosaccharide residues and a fatty acid of variable chain length but lacking the sialic acid residue present on ganglioside M2. Asialo-GM2 levels are low-to-undetectable in normal human brain, but it accumulates in the brain of patients with Tay-Sachs and Sandhoff disease, which are neurodegenerative disorders characterized by deficiency of lysosomal β-hexosaminidase A and B, respectively. It also binds to various bacteria, including Pseudomonas isolates derived from cystic fibrosis patients. Asialo-GM2 mixture contains gangliosideGM2 asialo molecular species with fatty acyl chains of variable lengths.